IFNG and neoplasm: The evaluation of interferon (IFN)γ and TGFβ gene promoter methylation showed that I2, especially in combination with chemotherapy, promoted the activation of anti-tumor genes IFNγ and silenced pro-oncogenic genes TGFβ.